103 related articles for article (PubMed ID: 2390680)
1. Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR.
Richer C; Mulder P; Doussau MP; Gautier P; Giudicelli JF
Br J Pharmacol; 1990 Jul; 100(3):557-63. PubMed ID: 2390680
[TBL] [Abstract][Full Text] [Related]
2. Perindopril, a new converting enzyme inhibitor: systemic and regional hemodynamics and sympathoinhibitory effects in spontaneously hypertensive rats.
Richer C; Doussau MP; Giudicelli JF
J Cardiovasc Pharmacol; 1986; 8(2):346-57. PubMed ID: 2422474
[TBL] [Abstract][Full Text] [Related]
3. Sympathoinhibitory effects of losartan in spontaneously hypertensive rats.
Moreau N; Richer C; Vincent MP; Giudicelli JF
J Cardiovasc Pharmacol; 1993 Jul; 22(1):126-34. PubMed ID: 7690084
[TBL] [Abstract][Full Text] [Related]
4. Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.
Richer C; Domergue V; Vincent MP; Giudicelli JF
Br J Pharmacol; 1996 Jan; 117(2):315-24. PubMed ID: 8789385
[TBL] [Abstract][Full Text] [Related]
5. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR.
Scalbert E; Richer C; Giudicelli JF
J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942
[TBL] [Abstract][Full Text] [Related]
6. [Interaction between SR 47436, a new angiotensin II antagonist and sympathetic nervous system in pithed SHR rats].
Moreau N; Richer C; Vincent MP; Giudicelli JF
Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1269-74. PubMed ID: 8129542
[TBL] [Abstract][Full Text] [Related]
7. Peripheral alpha 2-adrenoceptor-mediated sympathoinhibitory effects of mivazerol.
Richer C; Gobert J; Noyer M; Wülfert E; Giudicelli JF
Fundam Clin Pharmacol; 1996; 10(6):529-37. PubMed ID: 8985723
[TBL] [Abstract][Full Text] [Related]
8. Effects of cromakalim, a potassium channel opener, on regional blood flow in conscious spontaneously hypertensive rats.
Shoji T; Aki Y; Fukui K; Tamaki T; Iwao H; Abe Y
Eur J Pharmacol; 1990 Sep; 186(1):119-23. PubMed ID: 2282933
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacology of Ro 31-6930, a new potassium channel opener.
Paciorek PM; Burden DT; Burke YM; Cowlrick IS; Perkins RS; Taylor JC; Waterfall JF
J Cardiovasc Pharmacol; 1990 Feb; 15(2):188-97. PubMed ID: 1689412
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
13. Systemic and regional pre- and post-junctional sympathoinhibitory effect of perindopril in spontaneously hypertensive rats.
Richer C; Doussau MP; Giudicelli JF
J Hypertens Suppl; 1986 Oct; 4(3):S513-6. PubMed ID: 3023592
[TBL] [Abstract][Full Text] [Related]
14. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
[TBL] [Abstract][Full Text] [Related]
16. [Potassium agonists: regional vasodilator profile in rats].
Richer C; Mulder P; Doussau MP; Giudicelli JF
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1333-7. PubMed ID: 2510669
[TBL] [Abstract][Full Text] [Related]
17. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG
Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
[TBL] [Abstract][Full Text] [Related]
19. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine.
Shen YT; Vatner SF
J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801
[TBL] [Abstract][Full Text] [Related]
20. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
McPherson GA; Stork AP
Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
